Lifecore Biomedical Inc (LFCR) Gross Profit Margin starting from the first quarter 2026 to first quarter 2024, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Lifecore Biomedical Inc   (NASDAQ: LFCR)


Lifecore Biomedical Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LFCR Gross Profit Margin (Mar 31 2026)
Q1 		(Sep 30 2025)
Q1 		(May 25 2025)
Q4 		(Feb 23 2025)
Q3 		(Nov 24 2024)
Q2
Y / Y Revenue Change -29.99 %
Seq. Revenue Change -27.05 %
Revenue In Millions $22.46
Gross Profit Margin 19.86 %
Gross Profit Margin Total Ranking # 2893
Gross Profit In Millions $4.46
Y / Y Gross Profit Change -59.74 %
Seq. Gross Profit Change -42.73 %


Commenting First Quarter 2026 Gross Profit Margin
Lifecore Biomedical Inc experienced contraction in Gross Profit by -42.73 % to $22 millions and Revenue by -27.05 %, while Gross Profit Margin fell to 19.86 %, below company*s average Gross Profit Margin.


Observing first quarter 2026 results within Major Pharmaceutical Preparations industry 133 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 2893.
Learn about Gross Margin
LFCR's Gross Profit Margin first quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 134
Healthcare Sector # 413
Overall # 2871

Gross Profit Margin Statistics
High Average Low
43.98 % 26.5 % 11.5 %
(May 26 2024)   (Aug 27 2023)


LFCR Gross Income Trends • More of LFCR's Profitabilty Ratios • LFCR Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
LFCR's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
LFCR's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for LFCR's Competitors
Gross Profit Margin Profit Margin for Lifecore Biomedical Inc 's Suppliers
Gross Profit Margin Profit Margin for LFCR's Customers

You may also want to know
LFCR's Annual Growth Rates LFCR's Profitability Ratios LFCR's Asset Turnover Ratio LFCR's Dividend Growth
LFCR's Roe LFCR's Valuation Ratios LFCR's Financial Strength Ratios LFCR's Gross Profit Growth
LFCR's Roa LFCR's Inventory Turnover Ratio LFCR's Growth Rates LFCR's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2026, within Major Pharmaceutical Preparations Industry Gross Profit MarginMar 31 2026 MRQ Gross ProfitMar 31 2026 MRQ Revenue
Evofem Biosciences Inc   54.39 %$ 0.489  Millions$ 0.899  Millions
Emergent Biosolutions Inc   53.88 %$ 84.100  Millions$ 156.100  Millions
Organon and Co   53.63 %$ 783.000  Millions$ 1,460.000  Millions
Siga Technologies Inc  52.89 %$ 3.302  Millions$ 6.243  Millions
Dr Reddy s Laboratories Limited  52.77 %$ 1,889.000  Millions$ 3,580.000  Millions
Reshape Lifesciences Inc  52.69 %$ 0.017  Millions$ 0.032  Millions
Prestige Consumer Healthcare Inc   51.82 %$ 146.299  Millions$ 282.299  Millions
Maravai Lifesciences Holdings Inc   51.29 %$ 33.701  Millions$ 65.701  Millions
Elite Pharmaceuticals Inc   50.98 %$ 20.772  Millions$ 40.748  Millions
Schrodinger Inc   50.43 %$ 29.547  Millions$ 58.587  Millions
Teva Pharmaceutical Industries Limited  49.51 %$ 1,972.000  Millions$ 3,983.000  Millions
Cv Sciences Inc   48.89 %$ 1.562  Millions$ 3.195  Millions
60 Degrees Pharmaceuticals Inc   47.12 %$ 0.076  Millions$ 0.162  Millions
Cryoport inc   45.85 %$ 21.913  Millions$ 47.798  Millions
Amneal Pharmaceuticals Inc   44.33 %$ 320.113  Millions$ 722.113  Millions
Amphastar Pharmaceuticals Inc   41.08 %$ 70.322  Millions$ 171.171  Millions
Nrx Pharmaceuticals Inc   40.92 %$ 0.437  Millions$ 1.068  Millions
Keenova Therapeutics Plc  39.91 %$ 186.600  Millions$ 467.600  Millions
Amarin Corp Plcuk  39.37 %$ 17.769  Millions$ 45.132  Millions
Opko Health Inc   36.84 %$ 45.755  Millions$ 124.196  Millions
Prophase Labs Inc   34.94 %$ 0.167  Millions$ 0.478  Millions
Pmgc Holdings Inc   33.79 %$ 0.230  Millions$ 0.682  Millions
Perrigo Company Plc  33.61 %$ 325.500  Millions$ 968.500  Millions
Viatris Inc   32.90 %$ 1,157.200  Millions$ 3,517.000  Millions
Phibro Animal Health Corporation  32.84 %$ 125.675  Millions$ 382.675  Millions
China Pharma Holdings Inc  29.03 %$ 0.285  Millions$ 0.984  Millions
Sunshine Biopharma Inc   26.96 %$ 2.181  Millions$ 8.089  Millions
Aditxt Inc   23.77 %$ 0.003  Millions$ 0.012  Millions
Lifecore Biomedical Inc   19.86 %$ 4.462  Millions$ 22.462  Millions
Bio Green Med Solution Inc   18.38 %$ 0.143  Millions$ 0.778  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.